WallStreetZenWallStreetZen

NASDAQ: REGN
Regeneron Pharmaceuticals Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

REGN past earnings growth

How has REGN's earnings growth performed historically?
Company
-8.54%
Industry
52.08%
Market
61.16%
REGN's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
REGN's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
REGN's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

REGN past revenue growth

How has REGN's revenue growth performed historically?
Company
7.76%
Industry
148.4%
Market
16.96%
REGN's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
REGN's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
REGN's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

REGN earnings and revenue history

Current Revenue
$13.1B
Current Earnings
$4.0B
Current Profit Margin
30.1%
REGN's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

REGN Return on Equity

Current Company
16.1%
Current Industry
-63.5%
Current Market
188%
REGN's Return on Equity (16.1%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when REGN announces earnings.

REGN Return on Assets

Current Company
12.6%
Current Industry
2.9%
REGN is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

REGN Return on Capital Employed

Current Company
14.41%
Current Industry
19.5%
REGN's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

REGN vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
REGN$13.12B$4.69B$3.95B+20.58%+10.34%
VRTX$9.87B$4.61B$3.62B+26.49%+11.26%
MRNA$6.85B-$3.32B-$4.71B+119.28%N/A
ARGX$38.62M-$209.00M-$320.71M+9.84%N/A
BNTX$4.15B$1.51B$1.01B+96.02%+386.87%
View Top Biotech Stocks

REGN earnings dates

Next earnings date
May 2, 2024

Regeneron Pharmaceuticals Earnings & Revenue FAQ

What were REGN's earnings last quarter?

On Invalid Date, Regeneron Pharmaceuticals (NASDAQ: REGN) reported Q4 2023 earnings per share (EPS) of $10.89, up 2.85% year over year. Total Regeneron Pharmaceuticals earnings for the quarter were $1.16 billion. In the same quarter last year, Regeneron Pharmaceuticals's earnings per share (EPS) was $11.21.

If you're new to stock investing, here's how to buy Regeneron Pharmaceuticals stock.

What was REGN's earnings growth in the past year?

As of Q2 2024, Regeneron Pharmaceuticals's earnings has grown -8.54% year over year. This is 60.62 percentage points lower than the US Biotechnology industry earnings growth rate of 52.08%. Regeneron Pharmaceuticals's earnings in the past year totalled $3.95 billion.

What is REGN's earnings date?

Regeneron Pharmaceuticals's earnings date is Invalid Date. Add REGN to your watchlist to be reminded of REGN's next earnings announcement.

What was REGN's revenue last quarter?

On Invalid Date, Regeneron Pharmaceuticals (NASDAQ: REGN) reported Q4 2023 revenue of $3.43 billion up 0.58% year over year. In the same quarter last year, Regeneron Pharmaceuticals's revenue was $3.41 billion.

What was REGN's revenue growth in the past year?

As of Q2 2024, Regeneron Pharmaceuticals's revenue has grown 7.76% year over year. This is 140.65 percentage points lower than the US Biotechnology industry revenue growth rate of 148.4%. Regeneron Pharmaceuticals's revenue in the past year totalled $13.12 billion.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.